Table 2.
Patient Characteristics
| Key Characteristics of Study Population | |||||
|---|---|---|---|---|---|
| All n = 532 (%) | Definite TB n = 66 (%) | Possible TB n = 32 (%) | Not TB n = 352 (%) | Unclassifiablea n = 82 (%) | |
| Enrollment Site | |||||
| Outpatients | 462 (86.8) | 47 (71.2) | 15 (46.9) | 335 (95.2) | 65 (79.3) |
| Inpatients | 70 (13.2) | 19 (28.8) | 17 (53.1) | 17 (4.8) | 17 (20.7) |
| Median age in years (IQR) | 38 (31–45) | 37 (29–43) | 37 (34–44) | 39 (31–45) | 38 (32–45) |
| Female | 354 (66.5) | 39 (59.4) | 19 (59.4) | 245 (69.6) | 51 (62.2) |
| Median CD4 cell count per µL (IQR)b | 152 (44–349) | 108 (43–190) | 45 (12–179) | 216 (76–410) | 56 (16–220) |
| CD4 ≤100 cells/µL | 192 (37.7) | 32 (50.0) | 19 (63.3) | 97 (28.4) | 44 (59.5) |
| CD4 >100 cells/µL | 318 (62.3) | 32 (50.0) | 11 (36.7) | 245 (71.6) | 30 (40.5) |
| Median BMI (IQR) | 21 (18–23) | 18 (16–20) | 18 (16–22) | 21 (19–25) | 20 (17–22) |
| Positive WHO symptom screenc | 457 (86.2) | 63 (95.5) | 30 (93.8) | 295 (83.8) | 69 (86.3) |
| Previous history of TBd | 35 (6.6) | 5 (7.6) | 3 (9.4) | 22 (6.3) | 5 (6.3) |
| FujiLAM positive | 97 (18.2) | 49 (74.2) | 14 (43.8) | 27 (7.8) | 7 (8.5) |
| AlereLAM positive | 57 (10.7) | 35 (53.3) | 8 (25.0) | 9 (2.6) | 5 (6.1) |
| Vital Status at 6 Months | |||||
| Alive | 372 (69.9) | 32 (48.5) | 15 (46.9) | 321 (91.2) | 4 (4.9) |
| Died | 71 (13.4) | 22 (33.3) | 13 (40.6) | 7 (2.0) | 29 (35.4) |
| LTFU | 89 (16.7) | 12 (18.2) | 4 (12.5) | 24 (6.8) | 49 (59.8) |
Abbreviations: BMI, body mass index; IQR, interquartile range; LTFU, loss to follow up; TB, tuberculosis; WHO, World Health Organization.
aUnclassifiables were excluded from primary analysis.
bCD4 count missing for 22 participants.
cWHO symptoms score missing for 2 participants.
dTB history missing for 4 participants.